Benitec Biopharma Limited EV/FCF

EV/FCF of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/FCF of Benitec Biopharma Limited is -0.39 (as of June 30, 2022)
  • EV/FCF for the quarter ending December 31, 2022 was 0.27 (a -169.11% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -140.36%
  • Annual EV/FCF for 2022 was -0.39 (a -46.81% decrease from previous year)
  • Annual EV/FCF for 2022 was -0.73 (a -856.3% decrease from previous year)
  • Annual EV/FCF for 2021 was 0.1 (a -246.67% decrease from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Benitec Biopharma Limited

Most recent EV/FCFof BNTC including historical data for past 10 years.

Interactive Chart of EV/FCF of Benitec Biopharma Limited

Benitec Biopharma Limited EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.27 -0.39 -0.69 -0.39
2021 -0.67 0.1 -1.14 0.1
2020 0.08 0.01 1.23 1.67 1.23
2019 0.71 0.32 0.5
2018 -0.64
2017 -0.74 -0.18
2016 -0.01 0.57
2015 0.75
2014 0.0
2013 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology